Newtyn Management’s Nuvation Bio NUVB Stock Holding History

Newtyn Management’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-215,000	Closed	-$357K	–	65
2023 Q1	$357K	Sell	215,000 -25,000	-10%	-$50.7K	0.07%	74
2022 Q4	$461K	Buy	240,000 +30,000	+14%	+$60.7K	0.1%	64
2022 Q3	$470K	Hold	210,000	–	–	0.1%	66
2022 Q2	$680K	Buy	+210,000	New	+$916K	0.13%	67
2021 Q1	–	Sell	-50,000	Closed	-$585K	–	111
2020 Q4	$585K	Buy	+50,000	New	+$520K	0.13%	47

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Newtyn Management's NUVB Position: Q2 2023 in Review

Newtyn Management sold out of Nuvation Bio (NUVB) in Q2 2023, closing a stake of 215,000 shares — an estimated $357K sold.

Newtyn Management first reported a position in NUVB in Q4 2020 and held it in 5 quarters. The position peaked at $680K in Q2 2022. 124 funds tracked by Wall St. Rank hold NUVB as of Q2 2023.

Newtyn Management reported no remaining Nuvation Bio position as of Q2 2023 after selling out during the quarter.
Newtyn Management sold 215,000 Nuvation Bio shares in Q2 2023, an estimated $357K.
Newtyn Management first reported a position in Nuvation Bio in Q4 2020 and held it in 5 quarters.
Newtyn Management's Nuvation Bio position peaked at $680K in Q2 2022.
124 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2023.

Based on Newtyn Management's 13F filing for Q2 2023, filed 14 Aug 2023.